- mer BP and CEPSA facilities ac- quired in March/April 2016. Volume from the newly expand- ed PTA facility in Rotterdam will mostly benefit 2018 since the impact in 2017 was offset with tie-in shutdowns
continuous improvement in margin from 2Q 2017 to 1Q 2019. The Integrated PET margin improvement since March 2019 in Asia region is expected to benefit IVL globally especially from the recent weakness in PX
and values the corporate governance for running the business in term of economics, social and environment together with all stakeholders’ benefit in order to enable us as a world- class energy company
benefit from structurally improving margins and capturing the volume opportunities. IVL has achieved notable progress on multiple strategic fronts and is increasingly well positioned to deliver sustainable
percent of total WCIH shares. 10. Opinion of the Company’s Board of Directors regarding the entering into the transaction The Board of directors considered that the said transaction will benefit to the
Company’s Board of Directors regarding the entering into the transaction The Board of directors considered that the said transaction will benefit to the Company operations which related with the main business
and its for the benefit of the Company and its shareholders as to expand opportunity in the entry into cosmeceuticals and medical business which is consumers-oriented goodwill , increase Group of
the entry into the Transaction is reasonable and its for the benefit of the Company and its shareholders as to expand opportunity in the entry into cosmeceuticals and medical business which is consumers
Purchase Agreement. Ref. WINNER 0009/20108 Page 10 of 10 11. Opinion of the Board of Directors The Board of Directors deems that the entry into the Transaction is created benefit of the Company and its